ClinicalTrials.gg
Not yet recruitingNCT07939464ACLR_RTPUpdated Nov 16, 2026

Study of the Integrated Biomechanics of the Lower Limbs and Trunk in Athletes of Different Age Groups During the Performance of Motor Tasks

An interventional study of Instrumented tests in Anterior Cruciate Ligament Injuries and Sport Injury, sponsored by Stefano Zaffagnini. Not yet recruiting at 1 site in Italy. Open to participants aged 12 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Stefano Zaffagnini · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Non-randomized
Ages
12 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 20 studies in Anterior Cruciate Ligament Injuries with a site in Italy — 9 open to participants now, 11 under way, none of them phase 3. Anterior Cruciate Ligament Injuries · Italy.

Planned enrollment
3rd of 10
52 · median 37
Started
2027
the only one that year
No phase
10 of 20
2 open now
Primary completion
2028-08
later than 8 of 10 live
Registered
20th of 20
by date
Lead sponsor
5 of 20
Stefano Zaffagnini

Among the 20 studies in Anterior Cruciate Ligament Injuries with a site in Italy, this one is the 3rd largest by planned enrollment of the 10 interventional ones that give a count, is the only one that started in 2027, is one of 10 with no phase, reaches primary completion later than 8 of the 10 other live ones, and was the 20th registered.

Anterior Cruciate Ligament Injuries

626 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 193 are open to participants now.

Browse Anterior Cruciate Ligament Injuries studies →

Open to participants now

9 of the 20 studies in Anterior Cruciate Ligament Injuries with a site in Italy are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 122 Anterior Cruciate Ligament Injuries studies recruiting now, 27 (22%) set no upper age limit and 92 (75%) stop at 75 or younger; 46 take children under 18; 21 take healthy volunteers.

This study: 12 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Anterior Cruciate Ligament Injuries with a site in Italy, or all of them as a file.
02

Study summary

Anterior cruciate ligament (ACL) injuries, particularly non-contact injuries, are among the most common injuries in team sports and frequently occur during cutting maneuvers. They are associated with a substantial risk of secondary injuries, especially in pediatric and adolescent athletes. Persistent biomechanical alterations, neurocognitive deficits, and suboptimal movement strategies may contribute to the risk of re-injury even after ACL reconstruction and return to sport.

The diagnosis of ACL injury and the indication for surgical treatment are primarily based on clinical assessment, including tests such as the anterior drawer, Lachman, and pivot shift tests, which evaluate anteroposterior laxity and rotational instability. Instrumented assessments, including the KT-1000 and KiRA accelerometer, can provide objective measurements of knee laxity and complement the clinical evaluation.

Several ACL reconstruction techniques and graft types are currently available, with the main goal of restoring anteroposterior and rotational knee stability, recovering function, and reducing the risk of subsequent injury. Despite favorable clinical outcomes and high rates of return to sport, athletes may continue to show deficits in neuromuscular control, functional performance, and high-intensity movement patterns after rehabilitation and return to sport.

Conventional return-to-sport assessments may therefore fail to detect residual deficits, particularly during dynamic and sport-specific movements. This highlights the need for objective and multidimensional assessment methods capable of quantitatively evaluating movement quality under ecologically valid conditions.

Although optoelectronic motion capture systems represent the gold standard for movement analysis, their use is mainly restricted to controlled laboratory settings, which may not fully reproduce the demands and natural movement patterns of sports activities. In contrast, wearable inertial sensors and markerless motion analysis based on pose-estimation algorithms allow objective, non-invasive, and ecologically valid assessment of complex movements in both clinical and sporting environments.

Given the high risk of re-injury and the evidence of persistent biomechanical alterations following ACL reconstruction, investigating movement patterns during sport-specific tasks is therefore of particular interest. Integrating wearable sensors and markerless motion analysis and comparing ACL-reconstructed athletes with healthy individuals may help identify residual biomechanical and neuromuscular alterations that are not detectable through conventional clinical assessment alone.

03

Conditions studied

  • Anterior Cruciate Ligament Injuries
  • Sport Injury
04

Who can participate

Ages eligible
12 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

### Patients

Inclusion criteria

  1. Age between 12 and 60 years at the time of surgery;
  2. Male and female patients;
  3. History of unilateral anterior cruciate ligament (ACL) injury;
  4. Patients who underwent single-bundle "Over-The-Top" ACL reconstruction with lateral extra-articular tenodesis and any associated procedures;
  5. Patients who received medical clearance to return to sport at least 12 months prior to the assessment;
  6. Patients who provided to participate in the study.

Exclusion criteria

  1. Patients who are no longer reachable;
  2. Patients who decline consent to participate in the study;
  3. Cardiopulmonary diseases;
  4. History of severe musculoskeletal injuries resulting in absence from sports activities for more than 28 days, unrelated to the index injury;
  5. Inability to perform the motor tests required by the study protocol;
  6. Discontinuation of sports activities after surgery.

    • Healthy Population

Inclusion criteria

  1. Age between 12 and 60 years;
  2. Male and female subjects;
  3. Subjects who have not undergone ACL reconstruction and have no history of relevant injuries or musculoskeletal conditions that could affect the performance of the motor tests or the planned kinematic assessments;
  4. Tegner Activity Scale score ≥5;
  5. Subjects who provided informed consent to participate in the study.

Exclusion criteria

  1. Subjects who decline consent to participate in the study;
  2. Cardiopulmonary diseases;
  3. Inability to perform the motor tests required by the study protocol.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Patients

    Participants with a history of unilateral anterior cruciate ligament (ACL) injury who underwent ACL reconstruction using the single-bundle "Over-The-Top" technique combined with lateral extra-articular tenodesis, with or without associated procedures. Participants must have received medical clearance to return to sport at least 12 months prior to the assessment.

    Behavioral: Instrumented tests

  • Active comparator
    Healthy Volunteers

    The healthy control group will consist of participants who have not undergone anterior cruciate ligament reconstruction and have no history of relevant musculoskeletal injuries or conditions that could affect the performance of the motor tasks or the planned kinematic assessments. Participants must have a Tegner Activity Scale score ≥ 5.

    Behavioral: Instrumented tests

Interventions

  • BehavioralInstrumented tests

    The outpatient visit will include the administration of subjective assessment questionnaires and the performance of clinical and instrumented tests. Sport-specific functional assessment will be conducted through field-based tests during the same study session, using inertial sensors and video-based motion analysis systems. Clinical and functional assessments will be performed concurrently during the same session, in a dedicated environment specifically equipped for this purpose.

06

What researchers measure

Primary outcomes

  1. Lysholm Knee Score

    It is a validated measurement scale that assesses knee function through 8 items designed to determine the condition of the knee in response to the functional demands of daily living activities. This assessment tool is used to evaluate surgical outcomes in patients who have undergone surgery for knee ligament or meniscal injuries. The final score is obtained by summing the scores of the individual items and ranges from 0 to 100. Scores are classified into the following categories: Excellent (95-100); Good (84-94); Fair (65-83); Poor (\<64).

    Time frame: 12 months after return to sport

Secondary outcomes

  1. International Knee Documentation Committee (IKDC)

    The IKDC is a validated subjective knee assessment questionnaire evaluating symptoms, sports and daily activities, and current knee function compared with pre-injury status. It consists of 10 items assessing pain, stiffness, swelling, locking, activity limitations, and knee function. The score ranges from 0 to 100, with higher scores indicating better knee function and fewer symptoms. Results can be classified as excellent (80-100), good (60-80), fair (30-60), or poor (0-30). For patients aged 10-18 years, the validated pediatric version (Pedi-IKDC) will be used.

    Time frame: 12 months after return to sport

  2. Hospital for Special Surgery Pediatric Functional Activity Brief Scale (HSS Pedi-FABS)

    For pediatric and adolescent patients (10-18 years), in addition to the IKDC, the HSS Pedi-FABS will be administered. This is a validated subjective assessment tool that measures the patient's level of physical activity. It evaluates the frequency of activities such as running, jumping, changes of direction, and high-demand sports activities, providing an overall estimate of the subject's activity level. The total score ranges from 0 to 30, with 30 representing the highest level of physical and functional activity.

    Time frame: 12 months after return to sport

  3. VAS

    It is a unidimensional quantitative 10-point numerical scale for pain assessment. The patient is asked to select the number that best describes the intensity of their pain at that specific moment, ranging from 0 to 10. A score of 0 indicates no pain, while 10 indicates the worst pain imaginable.

    Time frame: 12 months after return to sport

  4. Tegner Score

    The Tegner Activity Scale is used to assess an individual's level of physical activity on a scale ranging from 0 to 10, where 0 represents "disability" and 10 represents participation in competitive sports, such as national or international-level soccer. The Tegner Activity Scale is widely used to assess the level of physical activity in patients with knee disorders. In this study, the Tegner Score will be completed by the investigator through a patient interview.

    Time frame: 12 months after return to sport

  5. Artrometro KT-1000

    The KT-1000 is a routinely used objective assessment instrument that measures anterior tibial translation relative to the femur by applying a predefined anteriorly directed force to the tibia. Its use is part of routine clinical practice at the outpatient clinics of the II Orthopaedic and Traumatologic Clinic of the Rizzoli Orthopaedic Institute. It is used to quantitatively assess static anteroposterior knee laxity following anterior cruciate ligament reconstruction. The unit of measurement is millimeters.

    Time frame: 12 months after return to sport

  6. Accelerometro KiRA

    KiRA is a non-invasive device that enables the assessment of dynamic knee laxity during the pivot-shift phenomenon. Its use is part of routine clinical practice at the outpatient clinics of the II Orthopaedic and Traumatologic Clinic of the Rizzoli Orthopaedic Institute and is intended to quantify the extent of dynamic knee laxity with high precision. The unit of measurement is millimeters per second squared (mm/s²).

    Time frame: 12 months after return to sport

  7. Inertial Sensor-Based Motion Analysis

    Dynamic lower-limb and trunk movement will be assessed during sport-specific functional tests using CE-marked wearable inertial measurement units (IMUs), already available at the Institute. Sensors will be positioned on the trunk, pelvis, and lower limbs and wirelessly connected to a data acquisition system to record kinematic and dynamic parameters, including linear acceleration, angular velocity, and spatial orientation. A standardized calibration procedure and anthropometric measurements will be performed to ensure accurate biomechanical modelling. Participants will then perform predefined sport-specific tasks, such as sprinting and changes of direction, using their natural movement patterns. Data will be processed using dedicated software (e.g., MATLAB).

    Time frame: 12 months after return to sport

  8. Markerless Motion Analysis

    Dynamic lower-limb and trunk movement will be assessed during straight-line sprinting and soccer-specific tasks, such as changes of direction, using AI-based markerless video analysis. No markers or sensors will be applied to the patient. The system will estimate 2D and 3D kinematic parameters of the trunk, hip, knee, and ankle, including joint angles and limb symmetry, from video recordings acquired using one or multiple synchronized cameras. The analysis will be performed using the open-source Sports2D software installed locally at IRCCS Istituto Ortopedico Rizzoli, with data processed offline to ensure data protection. A dedicated MATLAB code will support video selection, extraction, and further processing of kinematic data. After processing and extraction of the study variables, the videos will be deleted to minimize the storage of potentially identifiable data. The procedure is non-invasive and does not involve additional risks to the patient.

    Time frame: 12 months after return to sport

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Aug 2028, 19 months later.

Of 278 non-industry interventional studies with no phase under Anterior Cruciate Ligament Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 70. This study's planned 19 months is below that.

Counting every sponsor, half of 287 studies reached it within 30 months; a quarter within 14 and three quarters within 70.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 29, 2026
First posted
Nov 16, 2026
StartEst.
Jan 2027
Primary completionEst.
Aug 31, 2028
CompletionEst.
Aug 31, 2028
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07939464
Lead sponsor
Stefano Zaffagnini
Responsible party
Stefano Zaffagnini (Full Professor Medicine and Surgery, University of Bologna, Istituto Ortopedico Rizzoli) — Sponsor-investigator
First posted
Nov 16, 2026
Start date
Jan 2027 (estimated)
Primary completion
Aug 31, 2028 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Nov 16, 2026

Study contacts

Stefano Zaffagnini
Contact
stefano.zaffagnini@ior.it
0516366075

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion